SOPHiA GENETICS announced a collaboration with Exactis Innovation, based in Montreal, Quebec, who will contribute to cancer research and data-driven decision-making through SOPHiA GENETICS' multimodal real-world data offering. Exactis Innovation is a non-profit network of hospital partners across Canada dedicated to improving cancer survivorship through the acceleration of data-driven decision-making. Exactis will join the SOPHiA DDM network and leverage the SOPHiA DDM platform to access global real-world data insights from multimodal datasets.

By joining the SOPHiA DDM network, Exactis researchers will access to a global network of data that will provide robust, diverse insights to help support research for its Canadian population. The collaboration will also enable Exactis to implement leading cancer testing solutions for its patient population, including MSK-ACCESS and MSK-IMPACT powered with SOPHiA DDM and HRD testing. The SOPHiA DDM Platform will support Exactis in its ability to increase the volume and speed of next- eneration sequencing testing and tumor profiling.